These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 660339)

  • 1. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.
    Becker DJ; Foley TP
    J Pediatr; 1978 Jun; 92(6):1011-5. PubMed ID: 660339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
    Lee WP; Lippe BM; La Franchi SH; Kaplan SA
    Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of diabetes insipidus with DDAVP.
    Kikugawa CA; Cortopassi RF; Ditmer DG; Okamoto WS
    Am J Hosp Pharm; 1977 Sep; 34(9):1013-7. PubMed ID: 906988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes insipidus treated by DDAVP.
    Short JR; Isles A
    Med J Aust; 1976 May; 1(20):756-7. PubMed ID: 958068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) by ineffective doses of clofibrate in diabetes insipidus.
    Radó JP; Marosi J
    Horm Metab Res; 1975 Nov; 7(6):527-8. PubMed ID: 1213665
    [No Abstract]   [Full Text] [Related]  

  • 6. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG
    N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
    Ohzeki T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):485-90. PubMed ID: 2986401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenic diabetes insipidus: management with dDAVP (1-desamino-8-D arginine vasopressin).
    Cobb WE; Spare S; Reichlin S
    Ann Intern Med; 1978 Feb; 88(2):183-8. PubMed ID: 626447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of DDAVP in cranial diabetes insipidus as compared to other antidiuretic drugs.
    Coculescu M; Antipa C; Cucu C
    Endocrinologie; 1977; 15(4):275-81. PubMed ID: 563614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin)].
    Limal JM; Mugner E; Czernichow P
    Arch Fr Pediatr; 1977 Dec; 34(10):965-72. PubMed ID: 610662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
    Radó JP; Marosi J; Fischer J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term treatment of central diabetes insipidus with oral DDAVP].
    Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
    Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L; Julesz J; László FA
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
    Radó JP; Marosi J; Fischer J
    Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP).
    Fjellestad A; Czernichow P
    Acta Paediatr Scand; 1986 Jul; 75(4):605-10. PubMed ID: 3529809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.